Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Convertible Debt (2016 - 2021)

Historic Convertible Debt for Fortress Biotech (FBIO) over the last 3 years, with Q3 2021 value amounting to $18.1 million.

  • Fortress Biotech's Convertible Debt changed N/A to $18.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $18.1 million, marking a year-over-year change of. This contributed to the annual value of $10.1 million for FY2017, which is 17513.68% up from last year.
  • Latest data reveals that Fortress Biotech reported Convertible Debt of $18.1 million as of Q3 2021.
  • In the past 5 years, Fortress Biotech's Convertible Debt registered a high of $18.1 million during Q3 2021, and its lowest value of $1.5 million during Q2 2017.